infertility
Conditions
Interventions
Group A:The initiation dose is determined according to the level of AMH, 150 IU for AMH 1.2-3 ng /mL and 137.5 IU for AMH 3-5 ng/mL.
Group B:The initiation dose is determined according to the level of AMH, 187.5 IU for AMH 1.2-3 ng/mL and 175 IU for AMH 3-5 ng/mL.
Group C:The initiation dose is determined according to the level of AMH, 225 IU for AMH 1.2-3 ng/mL and 212.5 IU for AMH 3-5 ng/mL.
Sponsors
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Eligibility
Sex/Gender
Female
Age
21 Years to 39 Years
Inclusion criteria
Inclusion criteria: 1. Age 1.1 ng/mL; 5. Basal sinus follicle count (AFC) > 5.
Exclusion criteria
Exclusion criteria: 1. Patients with polycystic ovary syndrome and polycystic ovary; 2. Decreased ovarian reserve function, previous history of low or high ovarian response, failure of two IVF cycles; 3. Hydrosalpinx, abnormal uterine morphology, adenomyosis, hyperprolactinemia, adrenal hyperplasia, thyroid disease, testicular puncture or microspermatology; 4. Those who have not signed informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Live birth rate of fresh cycle transplantation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Gonadotropin hormone dosage and duration;Serum estradiol (E2) levels;Number of oocytes retrieved;Good-quality embryo rate;Ovarian Hyper-stimulation Syndrome (OHSS) incidence rate;Embryo implantation rate;Cumulative live birth rate; | — |
Countries
China
Contacts
Public ContactXu Bei
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Outcome results
None listed